Abstract

The project is an educational poster displaying data from literature highlighting the promising effects of cannabidiol (CBD) in Treatment Resistant Epilepsies such as Dravet Syndrome (DS). It sheds light on the efficacy and growing use of CBD in children with DS and other epilepsy syndromes.

Description

44th Biennial Convention 2017 Theme: Influence Through Action: Advancing Global Health, Nursing, and Midwifery.

Author Details

Holly A. Stockhover, BSN, School of Nursing, Indiana University Purdue University - Columbus, Columbus, Indiana, USA

Sigma Membership

Alpha

Lead Author Affiliation

Indiana University-Purdue University Columbus, Columbus, Indiana, USA

Type

Poster

Format Type

Text-based Document

Study Design/Type

N/A

Research Approach

N/A

Keywords:

Cannabidiol, Children, Dravet Syndrome

Conference Name

44th Biennial Convention

Conference Host

Sigma Theta Tau International

Conference Location

Indianapolis, Indiana, USA

Conference Year

2017

Rights Holder

All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.

All permission requests should be directed accordingly and not to the Sigma Repository.

All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.

Acquisition

Proxy-submission

Additional Files

download (262 kB)

Share

COinS
 

Using cannabidiol in treatment resistant epilepsies: The efficacy of CBD in children with Dravet Syndrome

Indianapolis, Indiana, USA

The project is an educational poster displaying data from literature highlighting the promising effects of cannabidiol (CBD) in Treatment Resistant Epilepsies such as Dravet Syndrome (DS). It sheds light on the efficacy and growing use of CBD in children with DS and other epilepsy syndromes.